FierceBiotech

Cepheid, BioGX partner on PCR tests as monkeypox spreads

Though the global number of recorded monkeypox cases continues to climb—passing 4,100 last week, according to the Centers for Disease Control and Prevention (CDC)—many researchers and epidemiologists ...
Nasdaq

Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness

SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
The Business Journals

Birmingham-based BioGX developing PCR test for monkeypox

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A Birmingham company is working with Cepheid to develop a ...
Nasdaq

Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This ...
GEN

Cepheid Awarded $3.3-M NIAID Grant for TB Test Development

Cepheid received an STTR grant of $3.3 million from NIAID for development of sample processing cartridges for rapid PCR TB detection. “Cepheid has developed a PCR cartridge that detects the presence ...
Seeking Alpha

Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

Multiplex Vaginal Panel (MVP) delivers faster identification of three distinct conditions within an hour SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received ...